Interestingly, ALKBH5 can also enhance glioma resistance to TMZ by stimulating the expression of SOX2, which coincides with the role of METTL3 in stabilizing GSCs through the promotion of SOX2 expression. The gene discussed is METTL3; the disease is glioma.